Intravitreal triamcinolone acetonide: Valuation of retinal thickness changes measured by optical coherence tomography in diffuse diabetic macular edema

European Journal of Ophthalmology

Volumn 14, Issue 4, 2004, Pages 321-324

  Ferrari, Tommaso Micelli ^a,b   Sborgia, L ^a   Furino, C ^a   Cardascia, N ^a   Ferreri, P ^a   Besozzi, G ^a   Sborgia, C ^a  

^a UNIVERSITY OF BARI   (Italy)

^b POLICLINICO   (Italy)

Author keywords

Diabetic macular edema; Optical coherence tomography; Triamcinolone

Indexed keywords

TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIABETIC MACULAR EDEMA; DRUG EFFICACY; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE ABNORMALITY; LASER COAGULATION; OPTICAL COHERENCE TOMOGRAPHY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETINA ANGIOGRAPHY; RETINA MACULA EDEMA; RETINA MACULA LUTEA; VISUAL ACUITY;

EID: 4143059112     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210401400407     Document Type: Article

References (18)

1. Klein R, Klein BEK, Moss SE, Davis MD, de Mets DL. The Wisconsin Epidemiology Study of Diabetic Retinopathy. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthlmol 1984; 102: 520-6.
2. The Diabetic Retinopathy Study Research Group. Four risk factors for severe visual loss in diabetic retinopathy: the third report from the Diabetic Retinopathy Study. Arch Ophthalmol 1979; 97: 654-5.
3. Moss SE, Klein R, Klein B. The incidence of visual loss in a diabetic population. Ophthalmology 1988; 95: 1340-8.
4. Sparrow JM, McLeod BK, Smith TDW, Birch MK, Rosenthal AR. The prevalence of diabetic retinopathy and maculopathy and their risk factors in the non-insulin treated diabetic patients of an English town. Eye 1993; 7: 158-63.
5. Segato T, Midena E, Grigoletto F, et al. The epidemiology and prevalence of diabetic retinopathy in the Veneto Region of north east Italy. Diabetic Med 1991; 8: S11-6.
6. ETDRS Report no. 1. Photocoagulation for diabetic macular edema. Arch Ophthalmol 1985; 103: 1796-806.
7. Adam M, Jas S, Duker PB, et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002; 109: 920-7.
8. Tano Y, Chandler D, Machemer R. Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide. Am J Ophthalmol 1980; 90: 810-6.
9. Wilson CA, Berkowitz BA, Sato Y, et al. Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation. Arch Ophthalmol 1992; 110: 1155-9.
10. McDonald HR, Schatz H. Grid photocoagulation for diffuse macular edema. Retina 1985; 5: 65-72.
11. Wingate RJB, Beaumont PE. Intravitreal triamcinolone and elevated intraocular pressure. Aust NZ J Ophthalmol 1999; 27: 431-2.
12. McCuen BW, Bessler M, Tano J, et al. The lack of toxicity of intravitreal administered triamcinolone acetonide. Am J Ophthalmol 1979; 91: 785-8.
13. Machemer R, Sugita G, Tano Y. Treatment of intraocular proliferation with intravitreal steroids. Trans Am Ophthalmol Soc 1979; 77: 171-80.
14. Jonas JB, Sofker A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 2001; 132: 425-7.
15. Early Treatment Diabetic Retinopathy Study Research Group. ETDRS Report no. 3. Techniques for scatter and local photocoagulation treatment of diabetic retinopathy. Int Ophthalmol Clin 1987; 27: 254-64.
16. Early Treatment Diabetic Retinopathy Study Research Group. ETDRS Report no. 4. Photocoagulation for diabetic macular edema. Int Ophthalmol Clin 1987; 27: 265-72.
17. Lee CM, Olk RJ. Modified grid laser photocoagulation for diffuse diabetic macular edema. Long term visual results. Ophthalmology 1991; 98: 1594-602.
18. Frank RN. The mechanism of blood-retinal barrier breakdown in diabetes. Arch Ophthalmol 1985; 103: 1303-4.